Xeris Pharmaceuticals Inc. (XERS), with a market capitalization of $562 million, reported its fourth-quarter 2024 earnings, surpassing expectations with an earnings per share (EPS) of -0.03 ...

On the 31st of March, Arrowpoint Asset Management bought 2.3 million 2U, Inc. (NASDAQ:TWOU) shares for $88 million at an average ...

Xeris Pharmaceuticals Inc. (XERS), with a market capitalization of $562 million, reported its fourth-quarter 2024 earnings, surpassing expectations with an earnings per share (EPS) of -0.03, compared ...

IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report). The company’s shares closed last Friday at $3.83.

Xeris Pharmaceuticals is bringing research operations to the corporate hot spot, countering a cold leasing market and bucking a life sciences industry trend of ditching Chicago.

Medline Canada, Corporation, a leading manufacturer and distributor of healthcare supplies and equipment, today introduced Fitright® Extended Wear Stretch Briefs ? part of its system of continence ...

"I desired an improved means to travel in places where a wheelchair cannot maneuver," said an inventor, from Louisville, Ky. "This inspired me to create a chair that could easily be pushed and pulled ...